JOIN EVENT
Event ends
  • --
  • --
  • --
Organizers
James Turner

Event checklist

 
 
 
 

About this event

Waklert - a short note

Waklert or generic Armodafinil is a psychostimulant medication used in the treatment of excessive sleepiness conditions. An enantiomer by nature, Waklert has the added advantage of containing only the active R isomer in this structure. This enables it to work for longer periods on people with sleep disorders. Because of its effects being more pronounced than similar drugs like Modalert or Modvigil, it is more preferred by the general population for wakefulness and cognitive promoting effects. But every eugeroic is designed to be used for a particular time period and discontinued after a particular usage phase to avoid any issues with tolerance and overuse induced Side-effects. In this regard, let’s have a look at the tolerance level of Armodafinil that most users tend to ignore in the first place. Tolerance of Armodafinil Studies have shown the efficacy of Waklert and of its active ingredient Armodafinil to be consistent over a period of 12 weeks of treatment. The tolerance of the medication has been proven to be well under limits during this interval. Even used intermittently over a period of 2 years by patients with sleep apnea has not yielded negative results. The only requirement Waklert needs during this time period are to constantly monitor the blood pressure of the patients during this time period. Armodafinil for long term bipolar In another study conducted to evaluate the long-term safety of Armodafinil, the active ingredient of Waklert in bipolar depression, Armodafinil was found to be safe and well-tolerated as well. The study was conducted over a period of 6 months with the end results suggesting that the medication had the potential to be used long term in the treatment of bipolar grade 1 depression. Is it safe in the long run? For testing the long-term efficacy of Armodafinil, in diagnosed sleep disorder cases, a 743-person study was conducted on diagnosed subjects with narcolepsy, SWSD, and sleep apnea. Out of the total subjects, 474 individuals had apnea-induced sleep issues, 113 subjects had SWSD-induced sleep issues and 156 had narcolepsy. Armodafinil ( Waklert active ingredient) showed excellent results with very few side effects in all of these cases. For up to two years, Armodafinil showed satisfactory results with blood pressure being the only concern requiring regular monitoring. Studies have proved that Waklert has the potential to be used for up to 10 years for the treatment of juvenile Narcolepsy in people aged ( subjects aged 8-16 years ). The medication did not have any effect on their pre-existing mental illness and boosted their ability to stay awake and lead healthy, normal lives. However, the safety factor is subject to change for patients depending on their specific health conditions. Thus, it is imperative to ask your doctor about the same before you start taking Waklert. What about side effects? Common side effects associated with Waklert use include headache, nausea, and vomiting Other side effects include -dryness of mouth, gastrointestinal issues, and weight loss. Rarely maniac tendency, Steven Johnson's Syndrome, and depression with the risk of increased tolerance are said to be associated with the use of Waklert These side effects can be avoided by taking proper precautions while using the medication. Some of these precautions are - Use it as per the physician's treatment plan ( doses are modified as per his plan of action ) - Ensure about allergies before using the medication - Be careful about drug interactions ( using 2 medications simultaneously may harm the system) - Use genuine medication ( avoid expired, outdated, spurious products) - Ensure that you are eligible for use of the medication

Website:- https://www.buytapenta.com/product/waklert-150mg/

Prizes

Prizes are not published
More

Schedule

  • Tuesday
  • Schedule for the day is not published
  • Wednesday
  • Schedule for the day is not published
More

Rules

Rules are not published.